Hunan Fangsheng Pharmaceutical Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 729.815 million compared to CNY 583.151 million a year ago. Operating income was CNY 55.886 million compared to CNY 42.433 million a year ago. Net income was CNY 42.384 million compared to CNY 38.322 million a year ago. Basic earnings per share from continuing operations was CNY 0.1 compared to CNY 0.09 a year ago.